50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia copertina

50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia

50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia

Ascolta gratuitamente

Vedi i dettagli del titolo

A proposito di questo titolo

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia.

Ancora nessuna recensione